Purchase Order 75H70724P00031
- Not listed
- This is a firm fixed-price purchase order awarded by the Indian Health Service (IHS), a federal civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract, valued at $94,050.00, is for the delivery of CEPHEID TEST KITS to support the agency's medical testing needs. Cepheid is an experienced federal contractor, holding several Indefinite Delivery Vehicles (IDVs) with the Department of Veterans Affairs and IHS for molecular diagnostic products and...
- This federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, is for the delivery of COVID-19 test kits to the Department of Health and Human Services Indian Health Service. The firm fixed-price contract has a potential value of $173,730.00 and is set to be completed by April 5, 2023. Cepheid, as the prime contractor, will provide reagents, test kits, instruments, and testing platforms to support the clinical diagnostic programs of the Indian Health...
- The U.S. Indian Health Service awarded a $544,000.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, to provide COVID-19 test kits. This contract has no set-aside designation. Cepheid has previously received awards from federal agencies, including the Department of Veterans Affairs and the Defense Logistics Agency, to supply diagnostic testing equipment, reagents, and consumables. The company has also participated as a...
- The U.S. Indian Health Service awarded a $168,475.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions based in Sunnyvale, California. The contract is for the administrative modification to extend the period of performance to December 31, 2025. Cepheid provides comprehensive molecular diagnostic technologies to various federal agencies, including the Department of Veterans Affairs (VA), Indian Health Service (IHS), and Defense...
- The Indian Health Service awarded Cepheid Inc. a delivery order valued at $10,200.00 on October 27, 2021, for Fiscal Year 2022 COVID-19 testing kits. This firm fixed-price delivery order, with an ultimate completion date of November 26, 2021, represents a continuation of IHS's procurement of molecular diagnostic testing solutions to support tribal healthcare operations. The contract carries no set-aside designation, reflecting Cepheid's competitive positioning as a primary federal supplier of...
- This federal contract award is for Cepheid, a for-profit manufacturer of molecular diagnostic solutions, to provide CEPHEID 4PLEX+ COVID-19 TESTING KITS to the Indian Health Service (IHS). The award, valued at $402,084.00, is a firm fixed-price delivery order placed under an existing Indefinite Delivery Contract. The contract has no set-aside designation. Cepheid has previously received various federal contract awards and grants, including Blanket Purchase Agreements with the Department of...
- This federal contract award is for the procurement of COVID-19 testing kits by the Indian Health Service (IHS), a civilian agency within the U.S. Department of Health and Human Services. The contract, valued at $243,250.00, was awarded to Cepheid, a for-profit manufacturer of molecular diagnostic solutions including infectious disease tests. The contract is a firm fixed-price purchase order with an ultimate completion date of August 31, 2025. Cepheid is the prime contractor and there is no...
- This is a firm fixed-price contract awarded by the Indian Health Service (IHS), a civilian agency, to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions. The contract has a ceiling value of $73,894.16 and is for the delivery of laboratory testing supplies and services, with a period of performance through March 5, 2025. The contract is a Blanket Purchase Agreement (BPA) call, which allows the IHS to continuously procure Cepheid's molecular diagnostic solutions, including...
- The Indian Health Service (IHS) awarded a $204,000 firm fixed-price purchase order to Cepheid Inc., a leading manufacturer of molecular diagnostic solutions based in Sunnyvale, California, on December 31, 2025. The contract covers reagent testing kits for the IHS laboratory department, with an ultimate completion date of December 31, 2030. This award reflects no set-aside designation and represents a continuation of Cepheid's established relationship as a provider of molecular diagnostic...
- This is a federal contract award to Cepheid, a for-profit manufacturer of molecular diagnostic solutions, by the Indian Health Service (IHS), a civilian agency. The contract is a Blanket Purchase Agreement (BPA) with a ceiling value of $1,010,160.00 for the provision of CEPHEID LABORATORY REAGENTS, TEST KITS & SUPPLIES. The contract is a firm fixed-price type with a period of performance ending on February 11, 2025. The contract does not have a set-aside designation. Cepheid is the prime...
The U.S. Indian Health Service (IHS) awarded a $115,600.00 firm fixed-price purchase order contract to Cepheid Inc., a for-profit manufacturer of molecular diagnostic solutions, for the provision of CEPHEID TEST KITS. The contract has an ultimate completion date of July 10, 2025 and was awarded on January 30, 2024. Cepheid is a prime contractor that provides advanced diagnostic systems and test kits for infectious diseases, genetic conditions, and clinical testing to various federal agencies, including the Department of Veterans Affairs (VA) and the Defense Logistics Agency. This contract award is not associated with a set-aside designation. Cepheid also holds several significant federal contract Indefinite Delivery Vehicles (IDVs) with the IHS and VA, enabling these agencies to continuously procure Cepheid's molecular diagnostic solutions, including diagnostic equipment, reagents, test kits, and maintenance services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Funding Only Action | $54.4k | 6/18/25 | |
| P00001 | Close Out | ($58k) | 4/30/25 | |
| Not listed | Not listed | $119.5k | 1/31/24 |